EPIVAX THERAPEUTICS, INC.

Class 042: Medical research services in the field of cancer, namely, computational processing of cancer and normal protein sets; Class 044: Medical analysis services for the treatment of cancer, namely, analysis of cancer and normal protein sets

Computer software for processing cancer/normal protein sets, identifying high-quality specific neo-antigens, and designing personalized cancer vaccines; Medical testing and analysis of cancerous and normal protein sets for identifying high-quality patient specific neo-antigens for the purpose of diagnosis and treatment; Research, development, engineering and testing services in the field of personalized cancer vaccines; providing temporary use of non-downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines

Class 042: Research and development of personalized cancer vaccines; medical research in the field of cancer, namely, processing cancer and normal protein sets and identifying high-quality patient specific neo-antigens; Class 044: Medical analysis services for the treatment of cancer, namely, processing of cancer and normal protein sets and identifying high-quality patient specific neo-antigens